JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 2, 2005; DOI: 10.1124/jpet.105.087023


0022-3565/05/3143-1370-1377$20.00
JPET 314:1370-1377, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data supplement
Right arrow All Versions of this Article:
jpet.105.087023v1
314/3/1370    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vieira, L. B.
Right arrow Articles by Snutch, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vieira, L. B.
Right arrow Articles by Snutch, T. P.
Right arrowPubmed/NCBI databases
*Protein
*Substance via MeSH

NEUROPHARMACOLOGY

Inhibition of High Voltage-Activated Calcium Channels by Spider Toxin PnTx3-6{boxs}

Luciene B. Vieira, Christopher Kushmerick1, Michael E. Hildebrand, Esperanza Garcia, Antony Stea2, Marta N. Cordeiro, Michael Richardson, Marcus Vinicius Gomez, and Terrance P. Snutch

Biotechnology Laboratory, University of British Columbia, Vancouver, British Columbia, Canada (L.B.V., M.E.H., E.G., A.S., T.P.S.); Laboratório de Neurofarmacologia, Departamento de Farmacologia, Instituto de Ciências Biológicas-Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (L.B.V., C.K., M.V.G.); and Centro de Pesquisa Professor Carlos R. Diniz, Fundação Ezequiel Dias, Belo Horizonte, Brazil (M.N.C., M.R.)

Animal peptide toxins have become powerful tools to study structure-function relationships and physiological roles of voltage-activated Ca2+ channels. In the present study, we investigated the effects of PnTx3-6, a neurotoxin purified from the venom of the spider Phoneutria nigriventer on cloned mammalian Ca2+ channels expressed in human embryonic kidney 293 cells and endogenous Ca2+ channels in N18 neuroblastoma cells. Whole-cell patch-clamp measurements indicate that PnTx3-6 reversibly inhibited L-({alpha}1C/Cav1.2), N-({alpha}1B/Cav2.2), P/Q-({alpha}1A/Cav2.1), and R-({alpha}1E/Cav2.3) type channels with varying potency ({alpha}1B > {alpha}1E > {alpha}1A > {alpha}1C) and IC50 values of 122, 136, 263, and 607 nM, respectively. Inhibition occurred without alteration of the kinetics or the voltage dependence of the exogenously expressed Ca2+ channels. In N18 cells, PnTx3-6 exhibited highest potency against N-type (conotoxin-GVIA-sensitive) current. In contrast to its effects on high voltage-activated Ca2+ channels subtypes, application of 1 µM PnTx3-6 did not affect {alpha}1G/Cav3.1 T-type Ca2+ channels. Based on our study, we suggest that PnTx3-6 acts as a {omega}-toxin that targets high voltage-activated Ca2+ channels, with a preference for the Cav2 subfamily (N-, P/Q-, and R-types).


Received for publication March 30, 2005
Accepted May 31, 2005.

Address correspondence to: Dr. Marcus Vinícius Gomez, Departamento de Farmacologia, ICB-Universidade Federal de Minas Gerais, Avenida Antonio Carlos, 6627, Belo Horizonte, MG 30270-901 Brazil. E-mail: gomez{at}icb.ufmg.br




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Martin-Moutot, P. Mansuelle, G. Alcaraz, R. G. D. Santos, M. N. Cordeiro, M. E. De Lima, M. Seagar, and C. Van Renterghem
Phoneutria nigriventer Toxin 1: A Novel, State-Dependent Inhibitor of Neuronal Sodium Channels That Interacts with {micro} Conotoxin Binding Sites
Mol. Pharmacol., June 1, 2006; 69(6): 1931 - 1937.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.